Recombinant CD52 (Gatralimab Biosimilar) antibody

Catalog No. ABIN7597715

The Humanized Chimeric anti-CD52 (Gatralimab Biosimilar) antibody (ABIN7597715) specifically detects CD52 (Gatralimab Biosimilar). The antibody is reactive with Human samples.

Quick Overview for Recombinant CD52 (Gatralimab Biosimilar) antibody (ABIN7597715)

Target: CD52 (Gatralimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CD52 (Gatralimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD52 (Gatralimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Gatralimab Biosimilar Antibody

Specificity: Human epididymis-specific protein 5, CDW52, CAMPATH-1 antigen, Cambridge pathology 1 antigen, He5, HE5, Epididymal secretory protein E5, CD52, CDw52

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD52 (Gatralimab Biosimilar)

Target: CD52 (Gatralimab Biosimilar)

Alternative Name: Gatralimab Biosimilar

Target Type: Biosimilar

Background: Human epididymis-specific protein 5, CDW52, CAMPATH-1 antigen, Cambridge pathology 1 antigen, He5, HE5, Epididymal secretory protein E5, CD52, CDw52

UniProt: P31358

CAS-No: 1826020-80-7